QID 591328

Date Published: 2023-02-07

QID 591328: Siemens Mendix Improper Access Control Vulnerability (SSA-433782)

An improper access control vulnerability in Mendix applications was discovered.
In case of access to an active user session, the vulnerability could allow changing that user password bypassing password validations within a Mendix application.

AFFECTED PRODUCTS
The following versions of Mendix, a software platform to build mobile and web applications, are affected:
Mendix applications using Mendix 7: All versions prior to 7.23.31
Mendix applications using Mendix 8: All versions prior to 8.18.18
Mendix applications using Mendix 9: All versions prior to 9.14.0
Mendix applications using Mendix 9 (v9.6): All versions prior to 9.6.12
Mendix applications using Mendix 9 (v9.12): All versions prior to 9.12.2

QID Detection Logic (Authenticated):
QID checks for the Vulnerable version of Siemens using registry "HKLM\SOFTWARE\Siemens"

On Successful exploitation, the vulnerability could allow changing that user password by bypassing password validations within a Mendix application.

CVSS V3 rated as High - 7.5 severity.

CVSS V2 rated as Medium - 5 severity.

Solution

Customers are advised to refer to CERT MITIGATIONS section SSA-43378 for affected packages and patching details.

Vendor References

SSA-43378 - cert-portal.siemens.com/productcert/pdf/ssa-433782.pdf

CVEs related to QID 591328

CVE-2022-31257 |

Software Advisories

Advisory ID	Software	Component	Link
SSA-43378			cert-portal.siemens.com/productcert/pdf/ssa-433782.pdf

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].